Artrya Limited ( (AU:AYA) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Artrya Limited shares are climbing after the company signed a major five-year agreement with U.S. healthcare provider Cone Health, expanding the reach of its Salix AI cardiac imaging platform in the key U.S. market. The deal highlights growing commercial traction and a stronger foothold in cardiac imaging, which in turn has supported a more positive analyst view and an upbeat price target for Artrya’s stock.
More about Artrya Limited
YTD Price Performance: 647.17%
Average Trading Volume: 920,088
Technical Sentiment Signal: Hold
Current Market Cap: A$626M
For further insights into AYA stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.